Princeton University Considers Meningitis Vaccine

Monday, 18 Nov 2013 06:56 AM

 

  Comment  |
   Contact  |
  Print  
|  A   A  
  Copy Shortlink

Princeton University officials are deciding whether to give students a meningitis vaccine that hasn't been approved in the U.S. to stop the spread of the disease.

A decision could be made as early as Monday.

The Food and Drug Administration last week approved importing Bexsero for possible use on Princeton's campus. The vaccine is approved in Europe and Australia. It's the only vaccine for use against the type B meningococcal bacteria.

Health officials confirmed the Ivy league school's seventh case of meningitis last week. Six students and a visitor have been diagnosed since March.

Meningitis can be spread through kissing, coughing or lengthy contact.

The school told students to wash their hands, cover their mouths when coughing and not share items such as drinking glasses and eating utensils.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  Comment  |
   Contact  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Twitter to Track Which Apps Its Users Have

Wednesday, 26 Nov 2014 22:22 PM

If you use Twitter on your cellphone, the social media site will soon begin tracking which apps you use unless you activ . . .

Harry Reid: 'We Sure Do Like' Pope Francis

Wednesday, 26 Nov 2014 22:09 PM

Senate Majority Leader Harry Reid, a Mormon, says he's an unabashed fan of Roman Catholic Pope Francis. . . .

GSK Ebola Vaccine Fast-tracked for Human Trials

Wednesday, 26 Nov 2014 20:37 PM

Preliminary results in human volunteers are promising from U.S. trials of one of the leading Ebola vaccine candidates. . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved